Abstract
Hemoglobin rates, hematocrit and glucose-6-phosphate dehydrogenase (G6PD) and glutathione reductase activities were measured in 38 patients with paracoccidioidomycosis treated with ketoconazole or sulfadoxin, and in 13 normal individuals.
Ketoconazole-treated patients showed reduced G6PD and glutathione reductase activities. One of these patients was found to be G6PD-deficient and suffered a hemolytic episode during treatment, which, however, did not require interruption of therapy.
The authors suggest that patients showing an erythrocyte enzyme defect should be monitored hematologically during treatment with ketoconazole. They also suggest that ketoconazole is an oxidant drug in addition to being a possible inhibitor of antioxidant erythrocyte enzymes.
Similar content being viewed by others
References
Barbosa W & Vasconcelos WM de PV. Ação da sulfametoxazol associada ao trimetoprim na terapêutica da blastomicose sul americana. Rev Pat Trop 1973; 2:329–39.
Barraviera B. Malária causada pelo Plasmodium falciparum e a redução da metahemoglobina pela via das pentoses. Masters thesis. Faculdade de Medicina de Botucatu, Universidade Estadual Paulista ‘Júlio de Mesquita Filho,’ 1984.
Barraviera B. Malária causada pelo Plasmodium falciparum e avaliacão indireta da atividade da glutationa redutase e da deficiência de riboflavina, por meio da reduçã da metahemoglobina pela cistamina. Doctoral thesis. Faculdade de Medicina de Botucatu, Universidade Estadual Paulista ‘Júlio de Mesquita Filho,’ 1986.
Barraviera B & Machado PEA. Glutationa redutase e grupos SH reativos intraeritrocitários-Revisão. Arq Bras Med 1987; 61:399–403.
Barraviera B, Machado PEA & Meira DA. Glutathion reductase activity and its relation with riboflavin levels measured by methemoglobin reduction by cystamine in patients with malaria. Rev Inst Med Trop S Paulo 1988; 30:107–8.
Barraviera B, Mendes RP, Machado JM, Pereira PCM, de Souza JM & Meira DA. Avaliação do tratamento da paracoccidioidomicose pela cotrimazina(associação sulfadiazina e trimetoprim). Congresso Da Sociedade Brasileira De Medicina Tropical 1988; 24:44.
Borges M. Mechanism of action of antifungal drugs, with special reference to the imidazole derivatives. Review Infect Dis 1980; 2:520–24.
Borges M & Van Den Bossch H. The mode of action of antifungal drugs. In: Levine HB, ed. Ketoconazole in the management of fungal disease. New York: Adis Press, 1982: 25–47.
Borelli D, Bran JL, Fuentes J, Legendre R, Leiderman E, Levine HB, Restrepo A & Stevens DA. Ketoconazole, an oral antifungal laboratory and clinical assestment of imidazole drugs. Post Grad Med J 1979; 55:657–61.
Brewer GJ, Tarlov AR & Alving AS. The methaemoglobin reduction test for primaquine-type sensitivity of erythrocytes. J. Amer Med Ass 1962; 180:386–8.
Croos CE, Halliwell B, Borish ET, Pryor WA, Ames BN, Saul RL, McCord JM & Harman D. Oxygen radicals and human disease. Ann Intern Med 1987; 107:526–45.
De Nollin S, Van Belee H, Goossens F, Thoné F & Borgers M. Cytochemical and biochemical studies of yeast after ‘in vivo’ exposure to miconazole. Antimic Agen and Chemot 1977; 11:500–13.
Fiorillo AM & Martinez R. Exames complementares. In: Del Negro O, Lacaz CS & Fiorillo AM, eds. Paracoccidioidomicose (Blastomicose Sul Americana), São Paulo: Sarvier EDUSP, 1982: 265–9.
Grimes AJ. Human red cell metabolism. London: Blackwell, 1980.
Krungkrai SR & Yuthavong Y. The antimalarial action on Plasmodium falciparum of qinghaosu and artesunate in combination with agents modulate oxidant strees Trans Roy Soc Trop Med Hyg 1987: 81:710–4.
Marcondes J, Meira DA, Mendes RP, Pereira PCM, Barraviera B, Mota NGS & Morcelli J. Avaliação do tratamento da paracoccidioidomicose com o ketoconazole. Rev Inst Med Trop S Paulo 1984; 26:113–21.
Mendes RP, Marcondes J, Morcelli J, Franco MF & Pereira PCM. Tratamento de doentes com paracoccidioidomicose. Utilização do ketoconazole em esquema de curta duração. Rev Soc Bras Med Trop 1986: 19(Supl.):95.
Mendes RP. Paracoccidioidomicose. In: Meira DA, ed. Terapêutica de Doenças Infecciosas e Parasitárias. Rio de Janeiro: Epume 1987, cap. 28:175–82.
Moura RAA. Técnicas de laboratório. 2nd ed. São Paulo: Atheneu, 1982.
Negroni R, Gonzalez-Montaner IJ, Palma Beltrain O, Tuculet MA & Rey D. Resultados de ketoconazole (R-41400) en el tratamiento de la paracoccidioicomiçose y la histoplasmosis. Rev Arget Micol 1979; 2:12–8.
Paniker NV & Beutler E. The effect of methylene blue and diaminodiphenylsulfone on red cells reduced glutathione synthesis. J Lab Clin Med 1972; 80:481–7.
Pfaller MA & Krogstad DJ. Oxygen enhances the antimalarial activity of the imidazoles. Am J Trop Med Hyg 1983; 32:660–5.
Ribeiro DO, Nova terapêutica para a blastomicose. Publ Med (S. Paulo) 1940; 12:36–54.
Snedecor GW & Cochran WG. Statistical methods. 7th ed. Ames: Iowa State University, 1980.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Barraviera, B., Mendes, R.P., Pereira, P.C.M. et al. Measurement of glucose-6-phosphate dehydrogenase and glutathione reductase activity in patients with paracoccidioidomycosis treated with ketoconazole. Mycopathologia 104, 87–91 (1988). https://doi.org/10.1007/BF00436932
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00436932